ROI | Parameters | Dose distribution | ||
---|---|---|---|---|
Plan-O | Plan-T | Plan-B | ||
iGTV | V95% (%) | 100 | 99.93*, ** | 99.60* |
(99.39–100) | (88.88–100) | (82.088-100) | ||
D95% | 1.016 | 0.999*, ** | 0.994* | |
(0.960–1.082) | (0.926–1.057) | (0.915–1.054) | ||
D99% | 1.008 | 0.978*, ** | 0.967* | |
(0.953–1.073) | (0.769–1.031) | (0.790–1.024) | ||
Relative median dose | 1.037 | 1.033** | 1.032* | |
(1.008–1.110) | (1.008–1.110) | (0.982–1.103) | ||
HI | 1.037 | 1.076*, ** | 1.080* | |
(1.020–1.129) | (1.032–1.185) | (1.032–1.208) | ||
CTV | V95% | 100 | 99.67*, ** | 99.20* |
(99.58–100) | (95.918-100) | (93.46–100) | ||
D95% | 1.080 | 1.052*, ** | 1.030* | |
(1.025–1.172) | (0.957–1.143) | (0.924–1.136) | ||
D99% | 1.047 | 0.989*, ** | 0.966* | |
(0.997–1.154) | (0.611–1.113) | (0.668–1.104) | ||
Relative median dose | 1.139 | 1.140** | 1.037 | |
(1.085–1.211) | (1.093–1.181) | (1.082–1.187) | ||
Lungs | V5 (%) | 24.89 | 24.48 | 24.03 |
(11.54–48.05) | (11.44–47.40) | (10.74–47.69) | ||
V20 (%) | 16.37 | 17.17* | 16.70 | |
(6.04–30.99) | (7.29–32.04) | (7.70-32.55) | ||
Mean dose (Gy(RBE)) | 9.43 | 9.68 | 9.71 | |
(3.76–15.36) | (4.62–16.50) | (4.49–17.56) | ||
Heart | V40 (%) | 2.76 | 2.61** | 2.56 |
(0-11.31) | (0-12.38) | (0-13.48) | ||
Mean dose (Gy(RBE)) | 3.48 | 3.55** | 2.95 | |
(0.07–12.85) | (0.04–15.31) | (0.03–15.09) | ||
Spinal cord | Max dose (Gy(RBE)) | 26.44 | 24.55 | 27.74 |
(4.01–56.89) | (3.27–50.49) | (3.65–52.46) | ||
Esophagus | Max dose (Gy(RBE)) | 74.62 | 75.98 | 74.95* |
(4.05–86.02) | (3.67–87.80) | (3.82–87.65) | ||
Mean dose (Gy(RBE)) | 13.26 | 12.03** | 11.95 | |
(0.18–40.05) | (0.14–42.94) | (0.20-42.98) | ||
Bronchial tree | Max dose (Gy(RBE)) | 83.38 | 85.05*, ** | 86.12* |
(4.58–89.80) | (5.23–95.55) | (3.22–96.54) |